首页> 外国专利> Multiple myeloma, chronic lymphocytic leukemia, and improved diagnostic methods of B-cell non-Hodgkin's lymphoma, prognosis prediction method, and monitoring methods

Multiple myeloma, chronic lymphocytic leukemia, and improved diagnostic methods of B-cell non-Hodgkin's lymphoma, prognosis prediction method, and monitoring methods

机译:多发性骨髓瘤,慢性淋巴细胞性白血病以及B细胞非霍奇金淋巴瘤的改进诊断方法,预后预测方法和监测方法

摘要

P- present invention provides a method of diagnosing multiple myeloma (MM). In certain embodiments, a method of diagnosing the MM is, BCMA polypeptide detected in (a) detecting the amount of BCMA polypeptide or fragment thereof in a biological sample obtained from the subject, (b) step (a) the amount of the peptide or fragment thereof, comprising the steps of: comparing the amount detected in a predetermined cutoff value or control serum samples were compared to the amount of control serum samples of predetermined cutoff value or (b) increased amount of BCMA polypeptide or fragment in a biological sample of (a) comprises the steps of indicating the presence of MM, the biological sample is a serum sample or a subject of bone marrow mononuclear cells or peripheral blood mononuclear cells, it is a supernatant obtained from the culture.
机译:本发明提供了一种诊断多发性骨髓瘤(MM)的方法。在某些实施方案中,诊断MM的方法是在(a)检测得自所述受试者的生物样品中的BCMA多肽或其片段的量,(b)步骤(a)所述肽或其片段,包括以下步骤:比较在预定的临界值中检测到的量或将对照血清样品与具有预定的临界值的对照血清样品的量进行比较,或(b)在生物样品的生物样品中增加的BCMA多肽或片段的量。 (a)包括指示MM的存在的步骤,生物样品是血清样品或骨髓单核细胞或外周血单核细胞的受试者,其是从培养物中获得的上清液。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号